ISV - international society for vaccines 2024 annual congress
Ended Project Grant Awarded Last action
- Award ID
- R13AI186468
- Recipient
-
International Society Of Vaccines UEI GH8YJJML2ZN1
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $7,000
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Place of performance
- Worcester, MA 01605, USA
Award details come from USAspending.gov.
Description
- Abstract
- The international society for vaccines (ISV) is a not-for-profit membership organization founded in 1992 with members and delegates from 47 countries, holding annual congresses since 2007. The ISV annual congress is the world's largest non-commercial scientific conference for researchers interested in vaccines and immunotherapeutics and the underlying sciences. The topics include prophylactic and therapeutic vaccines of infectious and chronic diseases and cancer, and human and animal vaccines, including the intersection of one health. Presentations cover basic research through manufacturing and clinical trials. ISV intentionally rotates the sites of the meetings between asia, north america, and europe, in accessible locations for strong regional and international representation. ISV attracts renowned leaders in vaccine fields while simultaneously providing opportunities for scientists from low- and middle-income countries (lmics) to attend both virtually and in person, and for students and early career researchers (ecrs) to present and gain personalized feedback and mentoring by senior scientists. ISV is particularly committed to ensuring participation of female, underrepresented, and junior investigators. The 2024 ISV annual congress, to be held in seoul, south korea, aims to highlight the very latest ground-breaking developments in vaccine research, manufacturing, clinical development and implementation, and safety. Plenary and parallel sessions are devoted to current hot topics spanning diverse areas of vaccinology. Poster sessions will allow more free and diverse scientific exchange of early research findings. Funding from niaid R13 conference grant mechanism will provide critical support to lmic delegates and students in vaccinology.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $7,000 |
Quick answers
Who received award R13AI186468?
R13AI186468 was awarded to International Society Of Vaccines by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 19, 2024.
How much is award R13AI186468 worth?
$7,000 has been obligated on R13AI186468.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award